Insulin Pens and New Ways of Insulin Delivery

被引：4
作者：
Heinemann, Lutz [1 ]
机构：
[1] Science & Co, Dusseldorf, Germany
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2014年 / 16卷
关键词：
BASAL INSULIN; DEGLUDEC; GLARGINE; TYPE-1; PHASE-3; ASPART; TRIAL;
D O I：
10.1089/dia.2014.1506
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S44 / S55
页数：12
相关论文
共 6 条
[1]   Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes [J].
Heise, T. ;
Nosek, L. ;
Bottcher, S. G. ;
Hastrup, H. ;
Haahr, H. .
DIABETES OBESITY & METABOLISM, 2012, 14 (10) :944-950
[2]   Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes [J].
Heise, T. ;
Hermanski, L. ;
Nosek, L. ;
Feldman, A. ;
Rasmussen, S. ;
Haahr, H. .
DIABETES OBESITY & METABOLISM, 2012, 14 (09) :859-864
[3]   Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial [J].
Heller, Simon ;
Buse, John ;
Fisher, Miles ;
Garg, Satish ;
Marre, Michel ;
Merker, Ludwig ;
Renard, Eric ;
Russell-Jones, David ;
Philotheou, Areti ;
Francisco, Ann Marie Ocampo ;
Pei, Huiling ;
Bode, Bruce .
LANCET, 2012, 379 (9825) :1489-1497
[4]   Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial [J].
Niskanen, Leo ;
Leiter, Lawrence A. ;
Franek, Edward ;
Weng, Jianping ;
Damci, Taner ;
Munoz-Torres, Manuel ;
Donnet, Jean-Paul ;
Endahl, Lars ;
Skjoth, Trine Vang ;
Vaag, Allan .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (02) :287-294
[5]   Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials [J].
Ratner, R. E. ;
Gough, S. C. L. ;
Mathieu, C. ;
Del Prato, S. ;
Bode, B. ;
Mersebach, H. ;
Endahl, L. ;
Zinman, B. .
DIABETES OBESITY & METABOLISM, 2013, 15 (02) :175-184
[6]   Newer insulin analogs: advances in basal insulin replacement [J].
Zinman, Bernard .
DIABETES OBESITY & METABOLISM, 2013, 15 :6-10
1